CD4 and myeloid sarcoma: Although the frequency of Tregs in MS patients is similar to that in healthy controls, their suppressor function against autoreactive CD4+ T-cell responses is impaired.242,243 The resistance of effector T cells to Treg cell suppression has also been described as a mechanism of MS pathogenesis.